News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Nov 04, 2019
FARMINGDALE, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
- Nov 01, 2019Current NATESTO® supply to the United States remains unaffected
TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today provided an update on the temporary unavailability of NATESTO® in Canada and South Korea, following the...
- Oct 31, 2019
BRISBANE, Calif.--(BUSINESS WIRE)--Oct. 31, 2019-- Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies,...
- Oct 31, 2019Recent Equity Raise and Line of Credit Provides Working Capital and Strengthened Balance Sheet to Fund Growth and Profitability
BIOLASE, Inc. (Nasdaq: BIOL), the global leader in dental lasers, today announced that it has secured a $3 million revolving line of credit from Pacific Mercantile Bank ("the Bank"), the wholly...
- Oct 30, 2019
BRISBANE, Calif.--(BUSINESS WIRE)--Oct. 30, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies,...
- Oct 29, 2019
DxTerity Diagnostics has launched the IFN-1 Test for determining a systemic lupus erythematosus patient's type 1 interferon status and the risk of progressing to lupus nephritis. The firm launched...
- Oct 28, 2019
FARMINGDALE, N.Y., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that...
- Oct 24, 2019
BIOLASE, Inc. (Nasdaq: BIOL), the global leader in dental lasers, today announced the pricing of an underwritten public offering of 7,820,000 shares of its common stock at a price to the public of...
- Oct 23, 2019
TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced it will host a Key Opinion Leader (KOL) meeting on new, unique clinical evidence supporting the...
- Oct 23, 2019More Than 250 Dental Professionals Attended The Event To Learn The Latest Trends And Innovations In Dentistry From Leading Industry Experts
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, hosted the inaugural Advancing Dentistry Symposium in San Diego, California Oct. 18-19. More than 250 professionals in the dental...